ScholarIQanswers from OpenAlex & ORCID
David G. Standaert
ResearcherPublications, citations & collaboration network
David G. Standaert is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does David G. Standaert have?
ScholarIQindexed works
David G. Standaert has 440 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does David G. Standaert have?
ScholarIQcitation count
David G. Standaert has 33,096 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of David G. Standaert?
ScholarIQh-index
David G. Standaert has an h-index of 100 in OpenAlex.
What is the i10-index of David G. Standaert?
ScholarIQi10-index
David G. Standaert has an i10-index of 262 in OpenAlex.
What is the ORCID of David G. Standaert?
ScholarIQorcid
The ORCID for David G. Standaert is on the source record.
What is the OpenAlex record for David G. Standaert?
ScholarIQopenalex
The OpenAlex for David G. Standaert is on the source record.
What are the most-cited papers on David G. Standaert?
ScholarIQmost cited works
The Parkinson Progression Marker Initiative (PPMI)
Kenneth Marek, Danna Jennings, Shirley Lasch, Andrew Siderowf, Caroline M. Tanner, Tanya Simuni, Christopher S. Coffey, Karl Kieburtz, Emily Flagg, Sohini Chowdhury, Werner Poewe, Brit Mollenhauer, Paracelsus-Elena Klinik, Todd Sherer, Mark Frasier, Claire C. Meunier, Alice Rudolph, Cindy Casaceli, John Seibyl, Susan Mendick, Norbert Schuff, Ying Zhang, Arthur W. Toga, Karen Crawford, Alison B. Ansbach, Pasquale De Blasio, Michele Piovella, John Q. Trojanowski, Les Shaw, Andrew Singleton, Keith A. Hawkins, Jamie L. Eberling, Deborah W. Brooks, David Russell, Laura Leary, Stewart A. Factor, Barbara Sommerfeld, Penelope Hogarth, Emily Pighetti, Karen Williams, David G. Standaert, Stephanie Guthrie, Robert A. Hauser, Holly Delgado, Joseph Jankovic, Christine Hunter, Matthew Stern, Baochan Tran, Jim Leverenz, Marne Baca, Sam Frank, Cathi-Ann Thomas, Irene Hegeman Richard, Cheryl Deeley, Linda Rees, Fabienne Sprenger, Elisabeth Lang, Holly A. Shill, Sanja Obradov, Hubert Fernandez, Adrienna Winters, Daniela Berg, Katharina Gauss, Douglas Galasko, Deborah Fontaine, Zoltán Mari, Melissa Gerstenhaber, David J. Brooks, Sophie Malloy, Paolo Barone, Katia Longo, Tom Comery, Bernard Ravina, Igor D. Grachev, Kim P. Gallagher, Michelle Collins, Katherine L. Widnell, Suzanne Ostrowizki, Paulo Fontoura, Tony W. Ho, Johan Luthman, Marcel van der Brug, Alastair D. Reith, Peggy Taylor
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy
José Á. Obeso, María Stamelou, Christopher G. Goetz, Werner Poewe, Anthony E. Lang, Daniel Weintraub, David J. Burn, Glenda M. Halliday, Erwan Bézard, Serge Przedborski, Stéphane Lehéricy, David J. Brooks, John C. Rothwell, Mark Hallett, Mahlon R. DeLong, Connie Marras, Caroline M. Tanner, G. Webster Ross, J. William Langston, Christine Klein, Vincenzo Bonifati, Joseph Jankovic, Andrés M. Lozano, Günther Deuschl, Hagai Bergman, Eduardo Tolosa, Mayela Rodríguez‐Violante, Stanley Fahn, Ronald B. Postuma, Daniela Berg, Kenneth Marek, David G. Standaert, D. James Surmeier, C. Warren Olanow, Jeffrey H. Kordower, Paolo Calabresi, Anthony H.V. Schapira, A. Jon Stoessl
Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study
C. Warren Olanow, Karl Kieburtz, Per Odin, Alberto J. Espay, David G. Standaert, Hubert H. Fernandez, Arvydas Vanagunas, Ahmed A. Othman, Katherine L. Widnell, Weining Robieson, Yili Pritchett, Krai Chatamra, Janet Benesh, Robert Lenz, Angelo Antonini
Clinical development of a poly(2-oxazoline) (POZ) polymer therapeutic for the treatment of Parkinson’s disease – Proof of concept of POZ as a versatile polymer platform for drug development in multiple therapeutic indications
Randall W. Moreadith, Tacey X. Viegas, Michael D. Bentley, J. Milton Harris, Zhihao Fang, Kunsang Yoon, Bekir Dizman, Rebecca Weimer, Brendan P. Rae, Xiuling Li, Christoph Rader, David G. Standaert, Warren Olanow
Identification of genetic risk loci and causal insights associated with Parkinson's disease in African and African admixed populations: a genome-wide association study
Mie Rizig, Sara Bandrés‐Ciga, Mary B. Makarious, Oluwadamilola O. Ojo, Peter Wild Crea, Oladunni Abiodun, Kristin Levine, Sani Abubakar, Charles Achoru, Dan Vitale, Olaleye Adeniji, Osigwe Paul Agabi, Mathew J. Koretsky, Uchechi Agulanna, Deborah A Hall, Rufus Akinyemi, Tao Xie, Mohammed Ali, Ejaz A. Shamim, Ifeyinwa Ani-Osheku, Mahesh Padmanaban, Ohwotemu Arigbodi, David G. Standaert, Abiodun Bello, Marissa Dean, Cyril Erameh, Inas Elsayed, Temitope Farombi, Olaitan Okunoye, Bimbo Fawale, Kimberley J. Billingsley, Frank Imarhiagbe, Pilar Álvarez Jerez, Emmanuel Iwuozo, Breeana Baker, Morenikeji Komolafe, Laksh Malik, Paul Nwani, Kensuke Daida, Ernest Nwazor, Abigail Miano‐Burkhardt, Yakub Nyandaiti, Zih‐Hua Fang, Yahaya Obiabo, Jillian H. Kluss, Olanike Odeniyi, Dena Hernández, Francis Odiase, Nahid Tayebi, FI Ojini, Ellen Sidranksy, Gerald Onwuegbuzie, Andrea D'Souza, Godwin Osaigbovo, Bahafta Berhe, Nosakhare Osemwegie, Xylena Reed, Olajumoke Oshinaike, Hampton L. Leonard, Folajimi Otubogun, Chelsea X. Alvarado, Shyngle Oyakhire, Simon Ozomma, Sarah Samuel, Funmilola Tolulope Taiwo, Kolawole Wasiu Wahab, Yusuf Zubair, Hirotaka Iwaki, Jonggeol Jeffrey Kim, Huw R. Morris, John Hardy, Mike A. Nalls, Karl Heilbron, Lucy Norcliffe‐Kaufmann, Njideka Okubadejo, Njideka Okubadejo, Oluwadamilola Ojo, Oladunni Abiodun, Charles Achoru, Osigwe Agabi, Uchechi Agulanna, Rufus Akinyemi, Mohammed Ali, Ifeyinwa Ani-Osheku, Ohwotemu Arigbodi, Abiodun Bello, Cyril Erameh, Temitope Farombi, Michael Fawale, Frank Imarhiagbe, Emmanuel Iwuozo, Morenikeji Komolafe, Paul Nwani, Ernest Nwazor, Yakub Nyandaiti, Yahaya Obiabo, Olanike Odeniyi, Francis Odiase, Francis Ojini, Gerald Onwuegbuzie